Foundation invests millions to find MS drug leads
The Myelin Repair Foundation has spent $10 million so far to identify 18 new drug leads for multiple sclerosis. The non-profit foundation says it plans to roll out the two best leads to pharma companies this summer, hoping for a licensing deal that will swiftly advance a new drug for MS.
The Foundation is helping blaze a path in new drug research, taking millions of dollars in donations and advancing experimental new therapies to the point that a drug company would want to in-license them for commercial development. And the Foundation is prepared to take a smaller payback in exchange for a faster development path.
- check out the report in the San Francisco Chronicle
Related Articles:
Natural protein used to combat multiple sclerosis. Report
Mass spectrometry helps ID two MS drugs. Report
Antibody stimulates natural repair of MS damage. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
